ALKERMES, INC. for ALKERMES, INC.
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Law Enforcement/Crime/Criminal Justice LAW
Preserving access to medications for patients with Serious Mental Illness;
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN JACKSON | — |
| PETER NORMAN | — |
Alcohol and Drug Abuse ALC
Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; H.R. 955 - Medicaid Reentry Act of 2021; H.R. 1319 - American Rescue Plan Act of 2021 (PL 117-2) Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022; Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, 2022; Interior, Environment, and Related Agencies Appropriations Act, 2022; Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT FORMAN | — |
| MEGAN JACKSON | — |
| PETER NORMAN | — |
| KRISTI THOMPSON | — |
Health Issues HCR
Awareness of the need for treatment system reform and access to all FDA-approved medications; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments; Awareness of outcomes data and the need for training on all medication assisted treatment; H.R.1319 - American Rescue Plan Act of 2021 (PL 117-2);
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN JACKSON | — |
| PETER NORMAN | — |
| KRISTI THOMPSON | — |
Medicare/Medicaid MMM
Maintain six protected classes for depressions and schizophrenia under Medicare Part D; Drug pricing reform within Medicare Part D
| Lobbyist | Covered position, as disclosed |
|---|---|
| MEGAN JACKSON | — |
| PETER NORMAN | — |
| KRISTI THOMPSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.